Skip to main content
. 2020 Apr 3;46:42. doi: 10.1186/s13052-020-0798-4

Fig. 1.

Fig. 1

Efficacy assessment. Streptococcus salivarius 24SMBc and Streptococcus oralis 89a showed a significant decrease of symptoms including episodes of fever, cough, bronchospasm, rhinorrhea, and otalgia (**p < 0.001)